Florence: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk

• Autor(es): Simonelli, C.
• Data: 2015
• Origem: Oasisbr
• Assunto(s): DOENÇAS HEMATOLÓGICAS
• Tipo de Documento: Artigo científico
• Idioma: Inglês